Rabies Virus Market – A Global and Regional Analysis

2.1    North America
2.1.1    Market Dynamics
2.1.2    Market Sizing and Forecast
2.1.2.1    North America Rabies Virus Market (by Country)
2.1.2.1.1    U.S.
2.1.2.1.2    Canada
2.2    Europe
2.2.1    Market Dynamics
2.2.2    Market Sizing and Forecast
2.2.2.1    Europe Rabies Virus Market (by Country)
2.2.2.1.1    Germany
2.2.2.1.2    France
2.2.2.1.3    U.K.
2.2.2.1.4    Spain
2.2.2.1.5    Italy
2.2.2.1.6    Rest-of-Europe
2.3    Asia-Pacific
2.3.1    Market Dynamics
2.3.2    Market Sizing and Forecast
2.3.2.1    Asia-Pacific Rabies Virus Market (by Country)
2.3.2.1.1    Japan
2.3.2.1.2    Rest-of-Asia-Pacific
2.4    Rest-of-the-World
2.4.1    Market Dynamics
2.4.2    Market Sizing and Forecast

3.1    Key Strategies and Development
3.1.1    Mergers and Acquisitions
3.1.2    Partnership, Alliances and Business Expansion
3.1.3    New Offerings
3.1.4    Regulatory Activities
3.1.5    Funding Activities
3.2    Company Profiles
3.2.1    Grifols, S.A.
3.2.1.1    Overview
3.2.1.2    Top Products/Product Portfolio
3.2.1.3    Top Competitors
3.2.1.4    Target Customers
3.2.1.5    Key Personnel
3.2.1.6    Analyst View
3.2.2    CSL Behring GmbH
3.2.2.1    Overview
3.2.2.2    Top Products/Product Portfolio
3.2.2.3    Top Competitors
3.2.2.4    Target Customers
3.2.2.5    Key Personnel
3.2.2.6    Analyst View
3.2.3    Mankind Pharma (Bharat Serums and Vaccines Limited).
3.2.3.1    Overview
3.2.3.2    Top Products/Product Portfolio
3.2.3.3    Top Competitors
3.2.3.4    Target Customers
3.2.3.5    Key Personnel
3.2.3.6    Analyst View
3.2.4    Bavarian Nordic A/S
3.2.4.1    Overview
3.2.4.2    Top Products/Product Portfolio
3.2.4.3    Top Competitors
3.2.4.4    Target Customers
3.2.4.5    Key Personnel
3.2.4.6    Analyst View
3.2.5    Kamada Ltd.
3.2.5.1    Overview
3.2.5.2    Top Products/Product Portfolio
3.2.5.3    Top Competitors
3.2.5.4    Target Customers
3.2.5.5    Key Personnel
3.2.5.6    Analyst View
3.2.6    Taibang Biotech Group Co., Ltd.
3.2.6.1    Overview
3.2.6.2    Top Products/Product Portfolio
3.2.6.3    Top Competitors
3.2.6.4    Target Customers
3.2.6.5    Key Personnel
3.2.6.6    Analyst View
3.2.7    Hualan Biological Vaccine Inc.
3.2.7.1    Overview
3.2.7.2    Top Products/Product Portfolio
3.2.7.3    Top Competitors
3.2.7.4    Target Customers
3.2.7.5    Key Personnel
3.2.7.6    Analyst View
3.2.8    Kedrion Biopharma Inc.
3.2.8.1    Overview
3.2.8.2    Top Products/Product Portfolio
3.2.8.3    Top Competitors
3.2.8.4    Target Customers
3.2.8.5    Key Personnel
3.2.8.6    Analyst View
3.2.9    Sanofi SA
3.2.9.1    Overview
3.2.9.2    Top Products/Product Portfolio
3.2.9.3    Top Competitors
3.2.9.4    Target Customers
3.2.9.5    Key Personnel
3.2.9.6    Analyst View
3.2.10    Others

Table:    Market Snapshot
Table:    Global Rabies Virus Market (by Region), $Million, 2024-2035
Table:    Global Rabies Virus Market, Dynamics Impact Analysis

Figure:    Global Rabies Virus Market Coverage
Figure:    Global Rabies Virus Market Key Trends, Impact Analysis, 2024-2035
Figure:    North America Rabies Virus Market, $Million, 2024-2035
Figure:    Europe Rabies Virus Market, $Million, 2024-2035
Figure:    Asia-Pacific Rabies Virus Market, $Million, 2024-2035